4h
HotCopper.com on MSNNeuren set for FDA talks on trial to treat developmental genetic disordersNeuren Pharmaceuticals (ASX: NEU) has been granted the chance to talk to the U.S. Food and Drug Administration (FDA) about ...
6h
Hosted on MSNSupernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Following a recall of grounding pads produced by Megadyne, a machinery industry company, the FDA is notifying veterinarians ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Other potential microplastics sources our experts brought up are fabrics that touch your skin often (clothing, bedding, ...
The health care advocacy group said removing health information to comply with Trump's executive orders worsens medical care ...
The Trump administration recently removed heath data from government websites, which spurred a federal lawsuit filed Tuesday ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
The physicians’ advocacy group Doctors for America is suing federal agencies for removing information from their websites ...
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results